Stockscreener 앱 받기
0.7525
2.94%
0.0215
시간 외 거래:
.75
-0.0025
-0.33%
전일 마감가:
$0.731
열려 있는:
$0.7341
하루 거래량:
842.31K
Relative Volume:
0.80
시가총액:
$80.27M
수익:
$34.42M
순이익/손실:
$-45.63M
주가수익비율:
-1.7508
EPS:
-0.4298
순현금흐름:
$-41.23M
1주 성능:
-9.88%
1개월 성능:
+2.72%
6개월 성능:
-50.49%
1년 성능:
-76.99%
1일 변동 폭
$0.7341
$0.7843
1주일 범위
$0.731
$0.8731
52주 변동 폭
$0.6434
$3.24
맥스사이트 Stock (MXCT) Company Profile
명칭
Maxcyte Inc
전화
301-517-5556
주소
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
0.7525 | 77.98M | 34.42M | -45.63M | -41.23M | -0.4298 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
맥스사이트 Stock (MXCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | 개시 | Stephens | Overweight |
| 2023-11-29 | 개시 | Craig Hallum | Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-24 | 개시 | BTIG Research | Buy |
| 2021-08-24 | 개시 | Cowen | Outperform |
| 2021-08-24 | 개시 | Stephens | Overweight |
| 2021-08-24 | 개시 | Stifel | Buy |
| 2021-08-24 | 개시 | Wedbush | Outperform |
| 2021-08-24 | 개시 | William Blair | Outperform |
모두보기
맥스사이트 주식(MXCT)의 최신 뉴스
MaxCyte (MXCT) CFO covers RSU tax withholding through automatic share sale - Stock Titan
MaxCyte, Inc. $MXCT Shares Bought by Mirabella Financial Services LLP - MarketBeat
Aug Setups: Is MaxCyte Inc showing insider buyingDip Buying & Daily Entry Point Alerts - baoquankhu1.vn
MaxCyte (MXCT) launches ExPERT DTx platform to accelerate high-throughput drug discovery - MSN
Buybacks Report: What is the next catalyst for MaxCyte Inc2026 Big Picture & Verified Trade Idea Suggestions - baoquankhu1.vn
Mirabella Financial Services LLP Purchases 1,600,000 Shares of MaxCyte, Inc. $MXCT - MarketBeat
MaxCyte (MXCT) Projected to Post Earnings on Tuesday - Defense World
MaxCyte (NASDAQ:MXCT) Stock Rating Upgraded by Wall Street Zen - Defense World
Risk Check: Should I average down on MaxCyte Inc stock2026 WrapUp & Daily Profit Focused Screening - baoquankhu1.vn
Insider Sell: Will MaxCyte Inc outperform tech stocksInflation Watch & High Conviction Buy Zone Alerts - baoquankhu1.vn
MaxCyte unveils new 96-well electroporation platform to accelerate discovery - Select Science
MaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Why MaxCyte Inc. stock attracts high net worth investorsBuy Signal & Intraday High Probability Setup Alerts - Naître et grandir
Options Flow: Can MaxCyte Inc sustain its profitabilityJuly 2025 Fed Impact & Safe Capital Growth Stock Tips - baoquankhu1.vn
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Update - MarketBeat
Free cash flow per share of MaxCyte, Inc. – FWB:MYE0 - TradingView
MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Analysts - MarketBeat
MaxCyte, Inc.Common Stock (NQ: MXCT - The Chronicle-Journal
MaxCyte unveils ExPERT DTx, a 96-well electroporation platform to accelerate discovery - marketscreener.com
MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery - Finviz
Insider Buy: Is MaxCyte Inc trading at a discountJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - baoquankhu1.vn
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery - The Manila Times
New MaxCyte lab device runs 96 cell samples in a three-minute cycle - Stock Titan
MXCT | MaxCyte, Inc. Common Stock FinancialsIncome Statement - Quiver Quantitative
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - The Manila Times
MaxCyte, Inc. to Release Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - Quiver Quantitative
MaxCyte schedules March 24 call on 2025 results for 4:30 p.m. ET - Stock Titan
MXCT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Market Leaders: What is BEDUs book value per shareWeekly Volume Report & Long-Term Growth Stock Strategies - baoquankhu1.vn
Take Profit: Is MaxCyte Inc a momentum stockJuly 2025 PostEarnings & Capital Protection Trading Alerts - baoquankhu1.vn
What are MaxCyte Inc.’s recent SEC filings showingMarket Activity Recap & Daily Profit Focused Stock Screening - mfd.ru
Dividend Watch: Is MaxCyte Inc forming a breakout patternWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
Day Trade: Will MaxCyte Inc benefit from rising consumer demand2025 Trading Volume Trends & Accurate Buy Signal Notifications - baoquankhu1.vn
Cadian Capital discloses 3.5% MaxCyte (MXCT) stake in latest 13G/A - Stock Titan
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Up 55.1% in January - MarketBeat
Is MaxCyte Inc. being accumulated by smart money2025 Institutional Moves & Daily Market Momentum Tracking - mfd.ru
Will MaxCyte Inc. stock outperform Nasdaq indexJuly 2025 Final Week & Consistent Profit Trade Alerts - mfd.ru
Is MaxCyte Inc. stock gaining market shareTreasury Yields & Short-Term High Return Ideas - mfd.ru
Capricorn Fund Managers Ltd Acquires 8,200,000 Shares in MaxCyte Inc - GuruFocus
Is MaxCyte Inc. stock a value trapJuly 2025 Review & Real-Time Stock Movement Alerts - mfd.ru
Will MaxCyte Inc. benefit from rising consumer demandBond Market & Community Trade Idea Sharing - mfd.ru
Brokerages Set MaxCyte, Inc. (NASDAQ:MXCT) PT at $7.00 - Defense World
MaxCyte (NASDAQ:MXCT) Upgraded to Hold at Wall Street Zen - MarketBeat
Capricorn Fund takes 7.7% stake in MaxCyte (NASDAQ: MXCT) - Stock Titan
MaxCyte (NASDAQ:MXCT) Stock Price Down 4.2%Here's Why - MarketBeat
Sentiment Recap: Can ATGL grow without dilutionQuarterly Growth Report & Technical Entry and Exit Tips - baoquankhu1.vn
MaxCyte team building boosts morale at sales meeting - Traders Union
Hedge Fund Moves: Will MaxCyte Inc outperform small cap indexes2025 Earnings Surprises & Reliable Intraday Trade Plans - baoquankhu1.vn
Aug Action: Is MaxCyte Inc showing insider buyingDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
IPO Launch: Is MaxCyte Inc showing insider buying2025 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Can MaxCyte Inc. disrupt its industryWeekly Loss Report & Daily Profit Maximizing Tips - mfd.ru
맥스사이트 (MXCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):